tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
Want to see CRSP full AI Analyst Report?

Crispr Therapeutics AG (CRSP) Technical Analysis

11,045 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 1.19, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 56.16, while Crispr Therapeutics AG’s (CRSP) share price is $60.9, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 54.43, while Crispr Therapeutics AG’s (CRSP) share price is $60.9, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Sep 05, 2026, 02:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.46
54.59
55.54
56.67
57.62
58.75
59.70
Fibonacci
54.59
55.38
55.88
56.67
57.46
57.96
58.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Sep 05, 2026, 02:27 PM
Period
Simple
Exponential
MA5
56.60Sell
56.66Sell
MA10
57.73Sell
56.93Sell
MA20
56.55Sell
56.16Sell
MA50
53.76Buy
54.43Buy
MA100
53.27Buy
53.81Buy
MA200
53.24Buy
54.91Buy
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 56.93, while Crispr Therapeutics AG’s (CRSP) share price is $60.9, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 53.81, while Crispr Therapeutics AG’s (CRSP) share price is $60.9, making it a Buy.
Crispr Therapeutics AG’s (CRSP) stock price is $60.9 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 53.76, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $60.9 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 53.27, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $60.9 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 53.24, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Sep 05, 2026, 02:27 PM
Name
Value
Implied Action
RSI (14)
50.70
Neutral
STOCH (9,6)
15.13
Buy
STOCHRSI (14)
42.85
Neutral
MACD (12,26)
1.19
Buy
ADX (14)
28.83
Neutral
Williams %R
-62.83
Buy
CCI (14)
-13.31
Neutral
ATR (14)
2.55
-
Ultimate Oscillator
48.83
Neutral
ROC
2.78
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 50.70, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 28.83, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -13.31, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 2.78, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 50.70, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 1.19, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 56.60, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 56.55, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 53.76, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 53.24, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -62.83, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -13.31, which suggests CRSP is a Neutral.